title: Will the BEAT-ROP study results really beat ROP?
authors: Seemant
authors: S
authors: Raizada
authors: Jamal Al
authors: JA
authors: Kandari
authors: Khalid Al
authors: KA
authors: Sabti
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000818:Animals; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D058449:Intravitreal Injections; D051379:Mice; D012178:Retinopathy of Prematurity / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab